Sebia

United States
Norcross, Georgia, United States, 30093

Company profile

Sebia company profile

Sebia is the provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.

Business identity

Phone number
33 1 69 89 80 80
Operating status
Active
Company type
For Profit
Employee range
501-1,000 employees
Revenue range
$1M-$10M
Founded
1967-01-01, Year

Headquarters

Postal code
30093
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding stage
M And A
Funding rounds
2
Last funding
Private Equity / 2017-08-11
Last equity funding
Private Equity
Investors
4
Lead investors
1
Founders
1
Articles
22
Exited on
2017-10-12

Founders and investors

Founders

Guy Barouh

Lead investors

La Caisse

Investors

AstorgHarbourVest PartnersLa CaisseMontagu